Cargando…

Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury

INTRODUCTION: Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Li, Cui, Rui, Peng, Lei, Ma, Jing, Chen, Xiao, Xie, Ru-Juan, Li, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159523/
https://www.ncbi.nlm.nih.gov/pubmed/25145540
http://dx.doi.org/10.1186/scrt489
_version_ 1782334236842262528
author Xing, Li
Cui, Rui
Peng, Lei
Ma, Jing
Chen, Xiao
Xie, Ru-Juan
Li, Bing
author_facet Xing, Li
Cui, Rui
Peng, Lei
Ma, Jing
Chen, Xiao
Xie, Ru-Juan
Li, Bing
author_sort Xing, Li
collection PubMed
description INTRODUCTION: Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of conditioned medium (CM) remains controversial. METHODS: In this study, we cultured mesenchymal stem cells (MSCs) and then transplanted them into an ischemia-reperfusion (I/R) injury model. CM was also injected into mice, and the histological changes, level of cell proliferation, loss of peritubular capillaries and anti-inflammatory and anti-apoptotic effects were examined at different time points. RESULTS: The results showed that MSC infusion improved renal function and histological alterations, leading to significantly reduced mortality. MSC administration also promoted kidney microvasculature repair, attenuated kidney peritubular capillary loss, increased the proliferation of parenchymal cells and decreased CD68-positive macrophage infiltration and apoptotic cells. Although we determined that CM contained proangiogenic factors, including hepatocyte growth factor (HGF), vascular endothelial growth factor-A (VEGF-A) and insulin-like growth factor-1 (IGF-1), no favorable effects were observed during the course of repair. CONCLUSIONS: Our data show that MSC infusion promotes kidney repair in a variety of ways, including enhancement of the repair of peritubular capillaries and tubular epithelial cells and anti-inflammatory and anti-apoptotic effects. MSCs can secrete high levels of proangiogenic growth factors, but CM results in a nonsignificant improvement, indicating that MSCs play a role in kidney repair through paracrine rather than endocrine mechanisms. These results indicate that MSC infusion is a promising therapeutic strategy for promoting kidney repair after injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt489) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4159523
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41595232014-09-11 Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury Xing, Li Cui, Rui Peng, Lei Ma, Jing Chen, Xiao Xie, Ru-Juan Li, Bing Stem Cell Res Ther Research INTRODUCTION: Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of conditioned medium (CM) remains controversial. METHODS: In this study, we cultured mesenchymal stem cells (MSCs) and then transplanted them into an ischemia-reperfusion (I/R) injury model. CM was also injected into mice, and the histological changes, level of cell proliferation, loss of peritubular capillaries and anti-inflammatory and anti-apoptotic effects were examined at different time points. RESULTS: The results showed that MSC infusion improved renal function and histological alterations, leading to significantly reduced mortality. MSC administration also promoted kidney microvasculature repair, attenuated kidney peritubular capillary loss, increased the proliferation of parenchymal cells and decreased CD68-positive macrophage infiltration and apoptotic cells. Although we determined that CM contained proangiogenic factors, including hepatocyte growth factor (HGF), vascular endothelial growth factor-A (VEGF-A) and insulin-like growth factor-1 (IGF-1), no favorable effects were observed during the course of repair. CONCLUSIONS: Our data show that MSC infusion promotes kidney repair in a variety of ways, including enhancement of the repair of peritubular capillaries and tubular epithelial cells and anti-inflammatory and anti-apoptotic effects. MSCs can secrete high levels of proangiogenic growth factors, but CM results in a nonsignificant improvement, indicating that MSCs play a role in kidney repair through paracrine rather than endocrine mechanisms. These results indicate that MSC infusion is a promising therapeutic strategy for promoting kidney repair after injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt489) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-21 /pmc/articles/PMC4159523/ /pubmed/25145540 http://dx.doi.org/10.1186/scrt489 Text en © Xing et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Xing, Li
Cui, Rui
Peng, Lei
Ma, Jing
Chen, Xiao
Xie, Ru-Juan
Li, Bing
Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
title Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
title_full Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
title_fullStr Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
title_full_unstemmed Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
title_short Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
title_sort mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159523/
https://www.ncbi.nlm.nih.gov/pubmed/25145540
http://dx.doi.org/10.1186/scrt489
work_keys_str_mv AT xingli mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury
AT cuirui mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury
AT penglei mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury
AT majing mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury
AT chenxiao mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury
AT xierujuan mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury
AT libing mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury